Reviews from patients with rheumatoid arthritis (RA) who post on social media about their medications are more positive than…
Read more
2 minutes to read
Results from a global registry for rheumatology patients with COVID-19 suggest hospital admission for the infection is less…
Read more
2 minutes to read
A head-to-head comparison of adalimumab and vedolizumab for the treatment of ulcerative colitis finds vedolizumab is…
Read more
The first head-to-head trial of two biologics for psoriatic arthritis suggests that, while adalimumab and ixekizumab are…
Read more
Patients with moderate to severe ulcerative colitis are more likely to achieve clinical remission and a range of other…
Read more
The interleukin (IL-4) and IL-13 inhibitor dupilumab is an effective treatment for patients with severe chronic…
Read more
About one in three patients with axial spondyloarthritis are likely to achieve inactive disease six months into therapy with…
Read more